Myriad Genetics traded at $19.49 this Wednesday September 28th, increasing $1.28 or 7.03 percent since the previous trading session. Looking back, over the last four weeks, Myriad Genetics gained 14.44 percent. Over the last 12 months, its price fell by 39.51 percent. Looking ahead, we forecast Myriad Genetics to be priced at 18.13 by the end of this quarter and at 16.56 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 123.72 2.11 1.74% -22.68%
Accelerate Diagnostics 1.70 0.02 1.19% -71.43%
Becton, Dickinson and Co. 230.37 2.03 0.89% -6.29%
Bio-Rad Laboratories 428.71 16.12 3.91% -42.78%
Biocept 0.90 0.03 3.46% -76.68%
Bruker 51.62 2.70 5.52% -34.72%
Quest Diagnostics 125.17 2.86 2.34% -15.24%
Danaher 266.24 6.14 2.36% -12.55%
Exact Sciences 34.44 2.47 7.73% -62.42%
Standard Biotools Inc 1.19 0.03 2.59% -81.35%
Hologic 65.23 1.52 2.39% -11.84%
Illumina 201.29 14.45 7.73% -51.10%
J&J 166.36 1.42 0.86% 1.43%
Mettler Toledo International 1,109.10 4.82 0.44% -21.25%
Myriad Genetics 19.49 1.28 7.03% -39.51%
NanoString Technologies 13.75 1.11 8.78% -70.17%
OraSure Technologies 4.02 0.36 9.84% -64.27%
Pacific Biosciences Of California 5.85 0.60 11.43% -76.47%
PerkinElmer 121.00 2.93 2.48% -30.88%
Quidel 73.34 3.48 4.98% -47.62%
Repligen 188.77 7.81 4.32% -34.04%
Thermo Fisher Scientific 517.83 9.17 1.80% -9.36%
Veracyte 17.40 0.45 2.65% -61.54%
Waters 272.75 2.26 0.84% -25.31%

Indexes Price Day Year
USND 11052 222.13 2.05% -23.85%

Myriad Genetics
Myriad Genetics, Inc. (Myriad) is a genetic testing and precision medicine company. Myriad is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. It operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can progress patient care. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. The Company's products include myRisk, BRACAnalysis, BRACAnalysis CDx myChoice CDx, Prolaris, EndoPredict, Foresight and Prequel.